Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes

NCT02477475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1595

Last updated 2017-06-21

No results posted yet for this study

Summary

The objective of this investigation is to collect following data in patients given NEXIUM capsule (NEXIUM) in usual post-marketing use.

Conditions

  • Reflux Esophagitis

Sponsors & Collaborators

Principal Investigators

  • Shigeru Yoshida, MD · AstraZeneca

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-07
Primary Completion
2017-02-20
Completion
2017-02-20

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02477475 on ClinicalTrials.gov